Cargando…

Non-target genetic manipulation induces rhabdomyosarcoma in KrasPten-driven mouse model of ovarian cancer

BACKGROUND: Genetically engineered mice are ideal models to advance our understanding the tumorigenesis of ovarian cancer. Our original objective was to establish an ovarian cancer model induced by Kras activation and Pten deletion. However, proficiently establishing the model remains a technical pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lai, Huiling, Guo, Yunyun, He, Weipeng, Sun, Tingting, Ouyang, Linglong, Tian, Liming, Li, Yuanyuan, Li, Xiaohui, You, Zeshan, Yang, Guofen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798327/ https://www.ncbi.nlm.nih.gov/pubmed/35117346 http://dx.doi.org/10.21037/tcr-20-2561

Ejemplares similares

Anaplastic carcinoma showing rhabdoid features combined with ovarian mucinous borderline cystadenoma: a case report and literature review
por: Sun, Tingting, et al.
Publicado: (2021)

Protein Panel of Serum-Derived Small Extracellular Vesicles for the Screening and Diagnosis of Epithelial Ovarian Cancer
por: Lai, Huiling, et al.
Publicado: (2022)

TBX2 represses PTEN in rhabdomyosarcoma and skeletal muscle
por: Zhu, Bo, et al.
Publicado: (2015)

SLC11A2: a promising biomarker and therapeutic target in ovarian cancer
por: Tian, Liming, et al.
Publicado: (2023)

Dualistic classification of high grade serous ovarian carcinoma has its root in spatial heterogeneity
por: Sun, Tingting, et al.
Publicado: (2022)

Synthetic essentiality between PTEN and core dependency factor PAX7 dictates rhabdomyosarcoma identity
por: Langdon, Casey G., et al.
Publicado: (2021)

Role of the YAP Oncoprotein in Priming Ras-Driven Rhabdomyosarcoma
por: Slemmons, Katherine K., et al.
Publicado: (2015)

The prognostic role of KRAS, BRAF, PIK3CA and PTEN in colorectal cancer
por: Eklöf, V, et al.
Publicado: (2013)

Iron out KRAS-driven cancer
por: Lei, Guang, et al.
Publicado: (2022)

Pax3 loss of function delays tumour progression in kRAS-induced zebrafish rhabdomyosarcoma models
por: Kahsay, A., et al.
Publicado: (2022)

MUC1 Positive, Kras and Pten Driven Mouse Gynecologic Tumors Replicate Human Tumors and Vary in Survival and Nuclear Grade Based on Anatomical Location
por: Tirodkar, Tejas S., et al.
Publicado: (2014)

Lentivirus-mediated shRNA interference of clusterin blocks proliferation, motility, invasion and cell cycle in the ovarian cancer cells
por: Fu, Yanxia, et al.
Publicado: (2015)

Effects of PTEN Loss and Activated KRAS Overexpression on Mechanical Properties of Breast Epithelial Cells
por: Linthicum, Will, et al.
Publicado: (2018)

Analysis of the relationship between the KRAS G12V oncogene and the Hippo effector YAP1 in embryonal rhabdomyosarcoma
por: Mohamed, Abdalla D., et al.
Publicado: (2018)

KRAS-driven ROS promote malignant transformation
por: Suh, Yongjoon, et al.
Publicado: (2015)

Twists and turns in Kras-driven tumor initiation
por: Maru, Yoshiaki, et al.
Publicado: (2021)

SRT2183 impairs ovarian cancer by facilitating autophagy
por: Sun, Tingting, et al.
Publicado: (2020)

Effects of Kras activation and Pten deletion alone or in combination on MUC1 biology and epithelial to mesenchymal transition in ovarian cancer
por: Zhang, Lixin, et al.
Publicado: (2016)

Strategies to inhibit FGFR4 V550L-driven rhabdomyosarcoma
por: Fiorito, Elisa, et al.
Publicado: (2022)

Combined Analysis of EGFR and PTEN Status in Patients With KRAS Wild-Type Metastatic Colorectal Cancer
por: Chen, Yu, et al.
Publicado: (2015)

EGFR, KRAS, BRAF, PTEN, and PIK3CA mutation in plasma of small cell lung cancer patients
por: Lu, Hong-Yang, et al.
Publicado: (2018)

Muscle synergies in joystick manipulation
por: Cai, Liming, et al.
Publicado: (2023)

Necroptosis‐related regulatory pattern and scoring system for predicting therapeutic efficacy and prognosis in ovarian cancer
por: Lai, Huiling, et al.
Publicado: (2023)

Behind the Wheel of Epithelial Plasticity in KRAS-Driven Cancers
por: Arner, Emily N., et al.
Publicado: (2019)

Brown Tumors Belong to the Spectrum of KRAS-driven Neoplasms
por: Turek, Daniel, et al.
Publicado: (2022)

PTPN2 regulates the activation of KRAS and plays a critical role in proliferation and survival of KRAS-driven cancer cells
por: Huang, Zhangsen, et al.
Publicado: (2021)

KRAS, BRAF and PIK3CA Mutations and the Loss of PTEN Expression in Chinese Patients with Colorectal Cancer
por: Mao, Chen, et al.
Publicado: (2012)

A novel mouse model of intrahepatic cholangiocarcinoma induced by liver-specific Kras activation and Pten deletion
por: Ikenoue, Tsuneo, et al.
Publicado: (2016)

Can Nimesulide Nanoparticles Be a Therapeutic Strategy for the Inhibition of the KRAS/PTEN Signaling Pathway in Pancreatic Cancer?
por: Ferreira, Roseane Guimarães, et al.
Publicado: (2021)

Molecular and Functional Characteristics of Ovarian Surface Epithelial Cells Transformed by KrasG12D and loss of Pten in a Mouse Model in vivo
por: Mullany, Lisa K., et al.
Publicado: (2011)

YAP manipulates proliferation via PTEN/AKT/mTOR-mediated autophagy in lung adenocarcinomas
por: Xu, Wei, et al.
Publicado: (2021)

Plasmon-driven nanowire actuators for on-chip manipulation
por: Linghu, Shuangyi, et al.
Publicado: (2021)

Combined HASPIN and mTOR inhibition is synergistic against KRAS-driven carcinomas
por: Xu, Chenyue, et al.
Publicado: (2022)

Immunoprevention of KRAS-driven lung adenocarcinoma by a multipeptide vaccine
por: Pan, Jing, et al.
Publicado: (2017)

Targeting copper metabolism to defeat KRAS-driven colorectal cancer
por: Aubert, Léo, et al.
Publicado: (2020)

Small-Molecule Inhibitors and Degraders Targeting KRAS-Driven Cancers
por: Hyun, Soonsil, et al.
Publicado: (2021)

Evaluation of PTEN, PI3K, MTOR, and KRAS expression and their clinical and prognostic relevance to differentiated thyroid carcinoma
por: Duman, Berna B., et al.
Publicado: (2014)

Corrigendum: A novel mouse model of intrahepatic cholangiocarcinoma induced by liver-specific Kras activation and Pten deletion
por: Ikenoue, Tsuneo, et al.
Publicado: (2017)

Caveolins in rhabdomyosarcoma
por: Rossi, Stefania, et al.
Publicado: (2011)

Relapsed Rhabdomyosarcoma
por: Heske, Christine M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nlkhn244hlksfotvclua3lrjo5